CHM Chimeric Therapeutics Limited
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Around Tuesday 24 November 2026
Estimated 52 weeks after the last AGM. This will update when the company announces its date or lodges its notice of meeting.
Second-strike watch
43.97% voted against the remuneration report at the last AGM, a strike. If 25% or more vote against it again, shareholders then vote on a spill resolution: whether to hold a meeting within 90 days at which the directors must stand for re-election.
Last AGM voting results
Results of the AGM held Tuesday 25 November 2025. Remuneration strike 25% or more voted against the remuneration report.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | To Adopt the Remuneration Report | 56.03% | 43.97% | carried |
| 2 | To re-elect Mr Paul Hopper as a Director | 49.14% | 50.86% | not carried |
| 3 | To elect Professor Henry Miles Prince as a Director | 92.56% | 7.44% | carried |
| 4 | Approval to issue Incentive Options to Director – Professor Henry Miles Prince | 70.69% | 29.31% | carried |
| 5 | Approval to issue Incentive Options to Director – Mr Paul Hopper | 37.82% | 62.18% | not carried |
| 6 | Approval to issue Equity Securities under Omnibus Incentive Plan | 57.52% | 42.48% | carried |
| 7 | capacity under Listing Rule | 84.67% | 15.33% | carried |
| 7.1A | (Special Resolution) | 75.42% | 24.58% | carried |
Protest vote: 20% or more against, or not carried.